Lenvatinib and tislelizumab versus atezolizumab and bevacizumab in combination with TAE-HAIC for unresectable hepatocellular carcinoma with high tumor burden: a multicenter retrospective cohort study
Titel:
Lenvatinib and tislelizumab versus atezolizumab and bevacizumab in combination with TAE-HAIC for unresectable hepatocellular carcinoma with high tumor burden: a multicenter retrospective cohort study
Auteur:
Cai, Hongjie Chen, Song Tang, Shuangyan Xiao, Yi Shi, Feng Wu, Zhiqiang Ma, Ping Chen, Huanwei Zhuang, Wenquan Guo, Wenbo